Literature DB >> 23430880

Adult-onset presentation of a hyperornithinemia-hyperammonemia-homocitrullinuria patient without prior history of neurological complications.

Kamer Tezcan1, Kristal T Louie, Yong Qu, Jorge Velasquez, Frank Zaldivar, Natalia Rioseco-Camacho, José Angel Camacho.   

Abstract

The Hyperornithinemia-Hyperammonemia-Homocitrullinuria (HHH) syndrome is a disorder of the urea cycle and ornithine degradation pathway caused by mutations in the mitochondrial ornithine transporter, ORNT1 (SLC25A15). In general, the majority of patients with HHH syndrome come to medical attention during infancy or early school years with symptoms such as learning disabilities, changes in cognitive development, spasticity, or liver dysfunction. In this report, we describe a 35-year-old male of Indian descent who was diagnosed with HHH syndrome after he presented to the emergency room with gastroenteritis, disorientation, and slurred speech. Molecular analysis revealed that this patient was heterozygous for two ORNT1 mutations, p.[Gly220Arg(+)Arg275X] (c.[658G>A(+)823C>T]) that had been previously reported in homozygous probands who presented during the first year of life. Cellular studies revealed that the ORNT1 p.Gly220Arg mutation was nonfunctional but targeted to the mitochondria. Given that this patient was a successful college graduate on a vegetarian diet without a prior history of learning or neurological impairment, additional factors such as gene redundancy, environmental, and epigenetic factors may have contributed to the delay in onset of presentation and lack of any previous symptoms. To the best of our knowledge, this is the first reported case of an adult-onset HHH syndrome presentation without a prior history of neurological or cognitive deficiency.

Entities:  

Year:  2011        PMID: 23430880      PMCID: PMC3509867          DOI: 10.1007/8904_2011_71

Source DB:  PubMed          Journal:  JIMD Rep        ISSN: 2192-8304


  12 in total

1.  Clinical and functional characterization of a human ORNT1 mutation (T32R) in the hyperornithinemia-hyperammonemia-homocitrullinuria (HHH) syndrome.

Authors:  José A Camacho; Rebecca Mardach; Natalia Rioseco-Camacho; Eduardo Ruiz-Pesini; Olga Derbeneva; Dario Andrade; Frank Zaldivar; Yong Qu; Stephen D Cederbaum
Journal:  Pediatr Res       Date:  2006-08-28       Impact factor: 3.756

2.  A novel R275X mutation of the SLC25A15 gene in a Japanese patient with the HHH syndrome.

Authors:  Hiroyuki Torisu; Ryutaro Kira; Naomi Kanazawa; Megumi Takemoto; Masafumi Sanefuji; Yasunari Sakai; Seiichi Tsujino; Toshiro Hara
Journal:  Brain Dev       Date:  2006-01-10       Impact factor: 1.961

Review 3.  Diseases caused by defects of mitochondrial carriers: a review.

Authors:  Ferdinando Palmieri
Journal:  Biochim Biophys Acta       Date:  2008-03-25

4.  Dual mechanism of brain damage induced in vivo by the major metabolites accumulating in hyperornithinemia-hyperammonemia-homocitrullinuria syndrome.

Authors:  Carolina Maso Viegas; Estela Natacha Brandt Busanello; Anelise Miotti Tonin; Alana Pimentel de Moura; Mateus Grings; Luciana Ritter; Patrícia Fernanda Schuck; Gustavo da Costa Ferreira; Angela Sitta; Carmen Regla Vargas; Moacir Wajner
Journal:  Brain Res       Date:  2010-11-05       Impact factor: 3.252

5.  Crystal structure and mechanism of human L-arginine:glycine amidinotransferase: a mitochondrial enzyme involved in creatine biosynthesis.

Authors:  A Humm; E Fritsche; S Steinbacher; R Huber
Journal:  EMBO J       Date:  1997-06-16       Impact factor: 11.598

6.  The human and mouse SLC25A29 mitochondrial transporters rescue the deficient ornithine metabolism in fibroblasts of patients with the hyperornithinemia-hyperammonemia-homocitrullinuria (HHH) syndrome.

Authors:  José A Camacho; Natalia Rioseco-Camacho
Journal:  Pediatr Res       Date:  2009-07       Impact factor: 3.756

7.  Cloning and characterization of human ORNT2: a second mitochondrial ornithine transporter that can rescue a defective ORNT1 in patients with the hyperornithinemia-hyperammonemia-homocitrullinuria syndrome, a urea cycle disorder.

Authors:  José A Camacho; Natalia Rioseco-Camacho; Dario Andrade; John Porter; Jin Kong
Journal:  Mol Genet Metab       Date:  2003-08       Impact factor: 4.797

8.  Hyperornithinemia, hyperammonemia, and homocitrullinuria syndrome with evidence of mitochondrial dysfunction due to a novel SLC25A15 (ORNT1) gene mutation in a Palestinian family.

Authors:  Stanley H Korman; Naomi Kanazawa; Bassam Abu-Libdeh; Alisa Gutman; Seiichi Tsujino
Journal:  J Neurol Sci       Date:  2004-03-15       Impact factor: 3.181

9.  Phenotypic variability among patients with hyperornithinaemia-hyperammonaemia-homocitrullinuria syndrome homozygous for the delF188 mutation in SLC25A15.

Authors:  F-G Debray; M Lambert; B Lemieux; J F Soucy; R Drouin; D Fenyves; J Dubé; B Maranda; R Laframboise; G A Mitchell
Journal:  J Med Genet       Date:  2008-11       Impact factor: 6.318

10.  Identification of novel mutations in the SLC25A15 gene in hyperornithinemia-hyperammonemia-homocitrullinuria (HHH) syndrome: a clinical, molecular, and functional study.

Authors:  Alessandra Tessa; Giuseppe Fiermonte; Carlo Dionisi-Vici; Eleonora Paradies; Matthias R Baumgartner; Yin-Hsiu Chien; Carmela Loguercio; Helene Ogier de Baulny; Marie-Cecile Nassogne; Manuel Schiff; Federica Deodato; Giancarlo Parenti; S Lane Rutledge; M Antonia Vilaseca; Mariarosa A B Melone; Gioacchino Scarano; Luiz Aldamiz-Echevarría; Guy Besley; John Walter; Eugenia Martinez-Hernandez; Jose M Hernandez; Ciro L Pierri; Ferdinando Palmieri; Filippo M Santorelli
Journal:  Hum Mutat       Date:  2009-05       Impact factor: 4.878

View more
  2 in total

1.  Ornithine In Vivo Administration Disrupts Redox Homeostasis and Decreases Synaptic Na(+), K (+)-ATPase Activity in Cerebellum of Adolescent Rats: Implications for the Pathogenesis of Hyperornithinemia-Hyperammonemia-Homocitrullinuria (HHH) Syndrome.

Authors:  Ângela Zanatta; Carolina Maso Viegas; Fernanda Hermes Hickmann; Wagner de Oliveira Monteiro; Angela Sitta; Daniela de Moura Coelho; Carmen Regla Vargas; Guilhian Leipnitz; Moacir Wajner
Journal:  Cell Mol Neurobiol       Date:  2015-03-13       Impact factor: 5.046

Review 2.  The hyperornithinemia-hyperammonemia-homocitrullinuria syndrome.

Authors:  Diego Martinelli; Daria Diodato; Emanuela Ponzi; Magnus Monné; Sara Boenzi; Enrico Bertini; Giuseppe Fiermonte; Carlo Dionisi-Vici
Journal:  Orphanet J Rare Dis       Date:  2015-03-11       Impact factor: 4.123

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.